Autologous hematopoietic cell transplantation, compared with CAR-T cell therapy, resulted in lower rates of relapse and improved progression-free survival in patients with relapsed large B-cell lymphoma while they were in complete response.
Related Keywords
, Mazyar Shadman , International Blood , National Cancer Institute , Clinical Research Division , Fred Hutch Cancer Center , Marrow Transplant Research , Innovators Network , Innovators Network Endowed Chair , News , Conference , Lymphoma ,
vimarsana.com © 2020. All Rights Reserved.